Euscaphic Acid

Euscaphic Acid

SCHEMBL17584886

C[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)C(=CCC4[C@@]5(C)C[C@@H](O)[C@@H](O)C(C)(C)C5CC[C@]43C)C2[C@]1(C)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SENP1 Q9P0U3 2/20 1.00
ACHE P22303 1/20 0.83
HSD11B1 P28845 3/20 0.81
PTPN1 P18031 9/20 0.78
PYGM P11217 2/20 0.73
PTPN2 P17706 2/20 0.73
GPBAR1 Q8TDU6 2/20 0.73
POLB P06746 1/20 0.73
PTPN6 P29350 1/20 0.73
HTT P42858 1/20 0.73
USP7 Q93009 1/20 0.73
AKR1B10 O60218 2/20 0.71
AKR1B1 P15121 2/20 0.71
GABRP O00591 1/20 0.61
GABRD O14764 1/20 0.61
GABRA1 P14867 1/20 0.61
GABRB1 P18505 1/20 0.61
GABRG2 P18507 1/20 0.61
GABRB3 P28472 1/20 0.61
GABRA5 P31644 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Euscaphic Acid SCHEMBL7349271 1.00 SENP1 (1.00) SENP1ACHEHSD11B1PTPN1PYGM
Euscaphic Acid SCHEMBL29228689 1.00 SENP1 (1.00) SENP1ACHEHSD11B1PTPN1PYGM
Tomentic Acid SCHEMBL94231 1.00 SENP1 (1.00) SENP1ACHEHSD11B1PTPN1PYGM
Euscaphic Acid SCHEMBL126037 1.00 SENP1 (1.00) SENP1ACHEHSD11B1PTPN1PYGM
Euscaphic Acid SCHEMBL869457 1.00 SENP1 (1.00) SENP1ACHEHSD11B1PTPN1PYGM
Euscaphic Acid SCHEMBL13629633 1.00 SENP1 (1.00) SENP1ACHEHSD11B1PTPN1PYGM
Euscaphic Acid SCHEMBL5971379 1.00 SENP1 (1.00) SENP1ACHEHSD11B1PTPN1PYGM
Euscaphic Acid SCHEMBL7349266 1.00 SENP1 (1.00) SENP1ACHEHSD11B1PTPN1PYGM
Euscaphic Acid SCHEMBL5799713 1.00 SENP1 (1.00) SENP1ACHEHSD11B1PTPN1PYGM
Euscaphic Acid SCHEMBL869924 1.00 SENP1 (1.00) SENP1ACHEHSD11B1PTPN1PYGM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160058797-A1 PHARMACEUTICAL COMPOSITION AND METHOD FOR REGENERATING MYOFIBERS IN THE TREATMENT OF MUSCLE INJURIES LEAD BILLION LIMITED (CN) 2016-03-03 US disclosed
US-20160058797-A1 PHARMACEUTICAL COMPOSITION AND METHOD FOR REGENERATING MYOFIBERS IN THE TREATMENT OF MUSCLE INJURIES LEAD BILLION LIMITED (CN) 2016-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160058797-A1 PHARMACEUTICAL COMPOSITION AND METHOD FOR REGENERATING MYOFIBERS IN THE TREATMENT OF MUSCLE INJURIES TNNC1, TNNI3, TNNT2 SENP1 2537/4885ACHE 316/4885HSD11B1 987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.